Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway.
Pharmaceuticals (Basel)
; 15(3)2022 Mar 10.
Article
in En
| MEDLINE
| ID: mdl-35337139
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Year:
2022
Type:
Article